Harriet Nuwagaba‐Biribonwoha

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock et al. · The Lancet · 2022 · 540 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

High attrition before and after ART initiation among youth (15–24 years of age) enrolled in HIV care

Matthew R. Lamb, Ruby Fayorsey, Harriet Nuwagaba‐Biribonwoha et al. · AIDS · 2013 · 213 citations · Full text

Public Health, Community Health, Infectious Disease Control +15

Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013.

Andrew F. Auld, Simon Agolory, Ray W. Shiraishi et al. · PubMed · 2014 · 123 citations · Full text

Public Health, Infectious Disease Control, Adolescent Health +15

Advanced HIV Disease at Entry into HIV Care and Initiation of Antiretroviral Therapy During 2006-2011: Findings From Four Sub-Saharan African Countries

María Lahuerta, Y. Wu, Susie Hoffman et al. · Clinical Infectious Diseases · 2013 · 102 citations · Full text

Public Health, Health Sciences, Infectious Disease Control +17

High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda

Batya Elul, Paulin Basinga, Harriet Nuwagaba‐Biribonwoha et al. · PLoS ONE · 2013 · 89 citations · Full text

Public Health, Community Health, Health Sciences +17